Fotemustine
Based on 1 publication(s) in Google Scholar
Fotemustine is a DNA-alkylating agent, with antitumor activity.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 92118-27-9
- 分子式: C9H19ClN3O5P
- 分子量:315.69
-
保管条件:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
-
HY-17394
CisplatinDNA Alkylator -
HY-13585
CarmustineDNA/RNA Alkylator -
HY-90006
5-FluorouracilThymidylate Synthase Inhibitor -
HY-17364
TemozolomideDNA Alkylator -
HY-17393
CarboplatinDNA Synthesis Inhibitor -
HY-B0078
DacarbazineAnticancer Agent -
HY-17419
IfosfamideDNA Alkylator/Crosslinker -
HY-17576
SatraplatinDNA Alkylator -
HY-13669R
Lomustine (Standard)DNA Alkylator -
HY-14573
SJG-136DNA Alkylator/Crosslinker -
HY-16503
TreosulfanAlkylating Cytotoxic Agent -
HY-B0181
AltretamineDNA Alkylator/Crosslinker
MedChemExpress（MCE）の使用を引用している文献 Fotemustine
More
生物活性
製品説明
IC50 & Target
DNA Alkylator[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-375 | IC50 |
173 μM
Compound: fotemustine
|
Cytotoxicity against human A375 cells after 96 hrs by MTT assay
Cytotoxicity against human A375 cells after 96 hrs by MTT assay
|
[PMID: 18513976] |
| A-375 | IC50 |
173 μM
Compound: Fotemustine
|
Cytotoxicity against human A375 cells after 96 hrs by MTT assay
Cytotoxicity against human A375 cells after 96 hrs by MTT assay
|
[PMID: 19278757] |
体外実験
Fotemustine is a DNA-alkylating agent. Fotemustine (800 μM) decreases GSH and intracellular GSSG levels but increases the extracellular GSSG-levels rapidly in isolated rat hepatocytes[1]. Fotemustine shows inhibitory effect on several tumor cell lines, with IC50s ranging form 0.05 to 0.18 mM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
化学情報
-
CAS 番号 92118-27-9
-
性状 Solid
-
分子量 315.69
-
分子式 C9H19ClN3O5P
-
Color White to yellow
-
SMILES
CC(P(OCC)(OCC)=O)NC(N(CCCl)N=O)=O
-
別名
S10036
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
J Mol Med (Berl)
2019 Aug;97(8):1183-1193. PMID: 31201471
溶剤 & 溶解度
体外:
DMSO : ≥ 3.2 mg/mL (10.14 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
プロトコル
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (418 KB)
- English - EN (418 KB)
- Français - FR (418 KB)
- Deutsch - DE (418 KB)
- Norwegian - NO (418 KB)
- Español - ES (418 KB)
- Swedish - SV (418 KB)
- Italian - IT (418 KB)
- Korean - KR (418 KB)
- Portuguese - PT (418 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Brakenhoff JP, et al. Molecular mechanisms of toxic effects of fotemustine in rat hepatocytes and subcellular rat liver fractions. Carcinogenesis. 1996 Apr;17(4):715-24. [Content Brief]
[2]. Merlin JL, et al. Enhancement of fotemustine (Muphoran) cytotoxicity by amifostine in malignant melanoma cell lines. Anticancer Drugs. 2002 Feb;13(2):141-7. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.1677 mL | 15.8383 mL | 31.6766 mL | 79.1916 mL |
| 5 mM | 0.6335 mL | 3.1677 mL | 6.3353 mL | 15.8383 mL | |
| 10 mM | 0.3168 mL | 1.5838 mL | 3.1677 mL | 7.9192 mL |
Fotemustine 関連分類
HY-B0733 関連分類
Powered by Bioz